Clinical Trial Update: Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma [Phase 2]

View source ↗

Summary

A Phase 2 trial is investigating pembrolizumab for advanced cutaneous sarcomas not including angiosarcoma; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Sarcoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Cutaneous Sarcoma | Phase 2 | Status: RECRUITING